These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 23918239

  • 1. Risk of arrhythmias associated with ipratropium bromide in children, adolescents, and young adults with asthma: a nested case-control study.
    Adimadhyam S, Schumock GT, Walton S, Joo M, McKell J, Lee TA.
    Pharmacotherapy; 2014; 34(4):315-23. PubMed ID: 23918239
    [Abstract] [Full Text] [Related]

  • 2. Risk of stroke associated with inhaled ipratropium bromide in chronic obstructive pulmonary disease: a population-based nested case-control study.
    Wang MT, Tsai CL, Lo YW, Liou JT, Lee WJ, Lai IC.
    Int J Cardiol; 2012 Jul 12; 158(2):279-84. PubMed ID: 22386700
    [Abstract] [Full Text] [Related]

  • 3. Drug use and pulmonary death rates in increasingly symptomatic asthma patients in the UK.
    Meier CR, Jick H.
    Thorax; 1997 Jul 12; 52(7):612-7. PubMed ID: 9246132
    [Abstract] [Full Text] [Related]

  • 4. Lack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway disease.
    Sin DD, Tu JV.
    Thorax; 2000 Mar 12; 55(3):194-7. PubMed ID: 10679537
    [Abstract] [Full Text] [Related]

  • 5. The association of asthma and atrial fibrillation--a nationwide population-based nested case-control study.
    Chan WL, Yang KP, Chao TF, Huang CC, Huang PH, Chen YC, Chen TJ, Lin SJ, Chen JW, Leu HB.
    Int J Cardiol; 2014 Sep 20; 176(2):464-9. PubMed ID: 25127961
    [Abstract] [Full Text] [Related]

  • 6. Inhaled anticholinergic drugs and risk of acute urinary retention.
    Afonso AS, Verhamme KM, Stricker BH, Sturkenboom MC, Brusselle GG.
    BJU Int; 2011 Apr 20; 107(8):1265-72. PubMed ID: 20880196
    [Abstract] [Full Text] [Related]

  • 7. Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis.
    Dockhorn R, Aaronson D, Bronsky E, Chervinsky P, Cohen R, Ehtessabian R, Finn A, Grossman J, Howland W, Kaiser H, Pearlman D, Sublett J, Ratner P, Settipane G, Sim T, Storms W, Webb R, Drda K, Wood C.
    Ann Allergy Asthma Immunol; 1999 Apr 20; 82(4):349-59. PubMed ID: 10227333
    [Abstract] [Full Text] [Related]

  • 8. Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study.
    Stephenson A, Seitz D, Bell CM, Gruneir A, Gershon AS, Austin PC, Fu L, Anderson GM, Rochon PA, Gill SS.
    Arch Intern Med; 2011 May 23; 171(10):914-20. PubMed ID: 21606096
    [Abstract] [Full Text] [Related]

  • 9. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department.
    Rodrigo GJ, Rodrigo C.
    Am J Respir Crit Care Med; 2000 Jun 23; 161(6):1862-8. PubMed ID: 10852758
    [Abstract] [Full Text] [Related]

  • 10. Risk of suicide attempt in asthmatic children and young adults prescribed leukotriene-modifying agents: a nested case-control study.
    Schumock GT, Stayner LT, Valuck RJ, Joo MJ, Gibbons RD, Lee TA.
    J Allergy Clin Immunol; 2012 Aug 23; 130(2):368-75. PubMed ID: 22698520
    [Abstract] [Full Text] [Related]

  • 11. Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma.
    Guite HF, Dundas R, Burney PG.
    Thorax; 1999 Apr 23; 54(4):301-7. PubMed ID: 10092690
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat Soft Mist Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma.
    von Berg A, Jeena PM, Soemantri PA, Vertruyen A, Schmidt P, Gerken F, Razzouk H.
    Pediatr Pulmonol; 2004 Mar 23; 37(3):264-72. PubMed ID: 14966821
    [Abstract] [Full Text] [Related]

  • 13. Mydriasis due to self-administered inhaled ipratropium bromide.
    Bond DW, Vyas H, Venning HE.
    Eur J Pediatr; 2002 Mar 23; 161(3):178. PubMed ID: 11998922
    [Abstract] [Full Text] [Related]

  • 14. [Association of A/T polymorphism of the CHRM2 gene with bronchodilator response to ipratropium bromide in asthmatic children].
    Szczepankiewicz A, Breborowicz A, Sobkowiak P, Kramer L, Popiel A.
    Pneumonol Alergol Pol; 2009 Mar 23; 77(1):5-10. PubMed ID: 19308904
    [Abstract] [Full Text] [Related]

  • 15. Effect of nebulized ipratropium on the hospitalization rates of children with asthma.
    Qureshi F, Pestian J, Davis P, Zaritsky A.
    N Engl J Med; 1998 Oct 08; 339(15):1030-5. PubMed ID: 9761804
    [Abstract] [Full Text] [Related]

  • 16. Comparison of nebulized ipratropium bromide with salbutamol vs salbutamol alone in acute asthma exacerbation in children.
    Watanasomsiri A, Phipatanakul W.
    Ann Allergy Asthma Immunol; 2006 May 08; 96(5):701-6. PubMed ID: 16729783
    [Abstract] [Full Text] [Related]

  • 17. Respiratory medications and the risk of cardiac arrhythmias.
    Huerta C, Lanes SF, García Rodríguez LA.
    Epidemiology; 2005 May 08; 16(3):360-6. PubMed ID: 15824553
    [Abstract] [Full Text] [Related]

  • 18. Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohort.
    Wilchesky M, Ernst P, Brophy JM, Platt RW, Suissa S.
    Chest; 2012 Aug 08; 142(2):305-311. PubMed ID: 22871756
    [Abstract] [Full Text] [Related]

  • 19. Lower arrythmogenic risk of low dose albuterol plus ipratropium.
    Yuksel H, Coskun S, Polat M, Onag A.
    Indian J Pediatr; 2001 Oct 08; 68(10):945-9. PubMed ID: 11758131
    [Abstract] [Full Text] [Related]

  • 20. Combined anticholinergic therapy in the management of acute asthma.
    Garrett JE.
    Respirology; 1997 Oct 08; 2 Suppl 1():S17-8. PubMed ID: 9400690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.